Leber Congenital Amaurosis — Genotyping Required for Possible Inclusion in a Clinical Trial
The genetic heterogeneity of LCA no longer needs to be demonstrated. Indeed, the six already known disease-causing genes and the two additional LCA loci only account for 45% of all patients. To this tremendous genetic heterogeneity corresponds an almost equivalent physiopathological heterogeneity and to a minor extent a clinical variability. Therefore, the identification of LCA-causing genes and subsequent genotyping is an obligatory prerequisite to classify patients and include them in clinical trials. For this reason, we have collected several consanguineous multiplex families affected with LCA and performed a genome-wide search for homozygosity. Three distinct chromosomal regions, different from the 8 already known LCA loci, have been identified for three unrelated families. The candidate genes lying in these regions are currently analyzed. On the other hand, very recently, encouraging therapeutic trials have been performed in order to propose gene therapy to the RPE65 subgroup. Nevertheless, to date in Europe, the major LCA gene is GUCY2D. It is why it seems important to us to develop a therapeutic approach for this group. A murine retinal explant model of pharmacological-induced GUCY2D deficiency is currently developed in our group. This model will be of primary importance to screen different drugs for their ability to slow, stop or reverse the phenotype.
KeywordsEurope Hydrocarbon Retina Leucine Laminin
Unable to display preview. Download preview PDF.
- Hollander, A.I., Heckenlively, J.R., Born, L.I., Kok, Y.J.M., Velde-Visser, S.D., Kellner, U., Jurklies, B., Schooneveld, M.J., Blankenagel, A., Rohrschneider, K. et al., 2001, Leber congenital amaurosis and retinitis pigmentosa with Coats-like exudative vasculopathy are associated with mutations in the Crumbs homologue 1 (CRBI) gene. Am. J. Hum. Genet. 69:198–203.CrossRefGoogle Scholar
- Gerber, S., Perrault, I., Hanein, S., Barbet, F., Ducroq, D., Ghazi, I., Martin-Coignard, D., Leowski, C., Homfray, T., Dufier, J.L. et al., 2001, Complete exon-intron structure of the RPGR-interacting protein (RPGRIPI) gene allows the identification of mutations underlying Leber congenital amaurosis. Eur. J. Hum. Genet. 9:561–571PubMedCrossRefGoogle Scholar
- Gerber S, Perrault I, Hanein S, Shalev S, Zlotogora J, Barbet F, Ducroq D, Dufier JL, Munnich A, Rozet JM, Kaplan J., 2002, A novel mutation disrupting the cytoplasmic domain of CRB I in a large consanguineous family of Palestinian origin affected with Leber congenital amaurosis. Ophthal. Genet. 22:3.Google Scholar
- Roepman, R., Bernoud-Hubac, N., Schick, D., Maugeri, A., Berger, W., Ropers, H.-H., Cremers, F.P.M. and Ferreira, P.A., 2000, The Retinitis Pigmentosa GTPase Regulator (RPGR) interacts with novel transport-like proteins in the outer segments of rod photoreceptors. Hum. Mol. Genet. 9: 2095–2105.PubMedCrossRefGoogle Scholar